Topical 5% tranexamic acid for the treatment of melasma in Asians: a double-blind randomized controlled clinical trial

Study Design
Subject Type
Human
Trial Design
Double-Blind, Randomised, Controlled
Trial Duration
84 days
Participants
25 (21 completed)
Age Range
32-45 years
Efficacy
Intervention(s) Outcome
Melasma
Sign in to read for free
Mechanisms
Intervention(s) Outcome
Melanin
Sign in to read for free
Side Effects
Intervention(s) Outcome
Irritation
Sign in to read for free
Skin Redness
Sign in to read for free
Study Summary
Sign in to read for free